Indegene IPO Details Today, GMP Price, Date, Review

Indegene IPO Details Today: Indegene IPO is Open on 6 May 2024 and Close on 8 May 2024. Indegene IPO to Raise 40,746,891 shares (Approx ₹1,841.76 Cr) via IPO. The Fresh Issue of 40,746,891 shares (Approx ₹1,841.76 Cr).

We are a “digital-first” commercialization company focused exclusively on the global life sciences industry. Our solutions enable biopharmaceutical, emerging biotech and medical devices companies develop products, launch them in the market, and drive sales through their life cycle in a more effective, efficient and modern manner.

We achieve this by combining over two decades of healthcare domain expertise and fit-for-purpose technology. Our portfolio of solutions cover all aspects of commercial, medical, regulatory and R&D operations of life sciences companies.

Life sciences enterprises require a talent pool with in-depth domain expertise on the journey of a drug or medical device from the research lab to the market to organize and analyze scientific and clinical data, navigate the regulatory landscape and the ethical guidelines within which the industry operates, and to develop the requisite medical content for healthcare professionals, patients, and payers. Scarcity of such talent is a major hindrance in operations. At the same time, drug pricing caps create margin pressures on biopharmaceutical companies, thus risking the overall profitability of the industry and consequently, operationsspend. While there are such talent gaps and margin pressures, life sciences companies are placing greater emphasis on digital innovation and enterprise-wide transformation initiatives to improve operational efficiencies.

Indegene IPO Date & Price Band Details

Indegene IPO Market Lot Details

Object of the Issue

1. Repayment/prepaymentof indebtedness of one of our Subsidiaries, ILSL Holdings, Inc.
2. Funding the capital expenditure requirements of our Company and our Material Subsidiary, Indegene,Inc.
3. Payment of consideration towards acquisition of additional shares in DT Associates Limitedby ILSL Holdings,Inc., a Subsidiary.
4. General corporate purposes and inorganic growth.

Indegene IPO Allotment & Listing Date (Details)

Indegene Anchor Investors

Indegene IPO Raise Fund Approx Rs. 548.78 Cr. from Anchor Investors. Indegene IPO bid Date Starts from 3 May 2024. Indegene IPO Anchor Investors List.

Indegene Financial Reports

Our Company Promoters-

N/A

Indegene Comparison Listed Industry Peers Group

N/A

Qualitative Factors

• Domain expertise in healthcare.
• Robust digital capabilities and in-house developed technology portfolio.
• Track record of establishing long-standing client relationships.
• Global delivery model.
• Experienced management and motivated talent pool supported by marquee investors.
• Track record of creating value through acquisitions.

Comparison of Accounting Ratios with Peer Group Companies.

N/A

Indegene Company Contact Details

Aspen Block G4, 3rdFloor
Manyata Embassy Business Park
Outer Ring Road, Nagawara
Bengaluru-560045
Karnataka India
Email:compliance.officer@indegene.com
Tel:+91 80 4674 4567
Website: www.indegene.com

Indegene IPO Registar

Link Intime India Private Limited
C-101, 1stFloor, 247 Park,
L.B.S. Marg,
Vikhroli West,Mumbai 400 083,
Maharashtra, India
Tel: +91 810811 4949
E-mail: indegene.ipo@linkintime.co.in
Investor grievance email: indegene.ipo@linkintime.co.in
Website:www.linkintime.co.in
Contact person: Shanti Gopalkrishnan